78 related articles for article (PubMed ID: 30859811)
21. Piperine (PP) enhanced mitomycin-C (MMC) therapy of human cervical cancer through suppressing Bcl-2 signaling pathway via inactivating STAT3/NF-κB.
Han SZ; Liu HX; Yang LQ; Cui LD; Xu Y
Biomed Pharmacother; 2017 Dec; 96():1403-1410. PubMed ID: 29169726
[TBL] [Abstract][Full Text] [Related]
22. Stat3 activation in human endometrial and cervical cancers.
Chen CL; Hsieh FC; Lieblein JC; Brown J; Chan C; Wallace JA; Cheng G; Hall BM; Lin J
Br J Cancer; 2007 Feb; 96(4):591-9. PubMed ID: 17311011
[TBL] [Abstract][Full Text] [Related]
23. Preclinical studies of TW-37, a new nonpeptidic small-molecule inhibitor of Bcl-2, in diffuse large cell lymphoma xenograft model reveal drug action on both Bcl-2 and Mcl-1.
Mohammad RM; Goustin AS; Aboukameel A; Chen B; Banerjee S; Wang G; Nikolovska-Coleska Z; Wang S; Al-Katib A
Clin Cancer Res; 2007 Apr; 13(7):2226-35. PubMed ID: 17404107
[TBL] [Abstract][Full Text] [Related]
24. Knockdown of hnRNP A2/B1 inhibits cell proliferation, invasion and cell cycle triggering apoptosis in cervical cancer via PI3K/AKT signaling pathway.
Shi X; Ran L; Liu Y; Zhong SH; Zhou PP; Liao MX; Fang W
Oncol Rep; 2018 Mar; 39(3):939-950. PubMed ID: 29328485
[TBL] [Abstract][Full Text] [Related]
25. Cisplatin cytotoxicity is increased by mifepristone in cervical carcinoma: an in vitro and in vivo study.
Jurado R; Lopez-Flores A; Alvarez A; García-López P
Oncol Rep; 2009 Nov; 22(5):1237-45. PubMed ID: 19787245
[TBL] [Abstract][Full Text] [Related]
26. [Effect and mechanism of an autophagy gene beclin 1 on cervical cancer HeLa cells].
Wang ZH; Li L; Duan ZL
Zhonghua Fu Chan Ke Za Zhi; 2011 Feb; 46(2):125-31. PubMed ID: 21426771
[TBL] [Abstract][Full Text] [Related]
27. A short Nur77-derived peptide converts Bcl-2 from a protector to a killer.
Kolluri SK; Zhu X; Zhou X; Lin B; Chen Y; Sun K; Tian X; Town J; Cao X; Lin F; Zhai D; Kitada S; Luciano F; O'Donnell E; Cao Y; He F; Lin J; Reed JC; Satterthwait AC; Zhang XK
Cancer Cell; 2008 Oct; 14(4):285-98. PubMed ID: 18835031
[TBL] [Abstract][Full Text] [Related]
28. A novel biphenyl urea compound, TPD7, stimulates apoptosis through modulating Fas signaling and Bcl-2 family proteins in cervical cancer.
Zhan Y; Zhang H; Dai B; Zhang Y; Zhang J; He L
Oncol Rep; 2018 Aug; 40(2):1064-1072. PubMed ID: 29901176
[TBL] [Abstract][Full Text] [Related]
29. Small-molecule inhibitors of Bcl-2 family proteins are able to induce tumor regression in a mouse model of pre-B-cell acute lymphocytic lymphoma.
Turner BC; Eves T; Refaeli Y
DNA Cell Biol; 2008 Mar; 27(3):133-42. PubMed ID: 18163880
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of oxidored-nitro domain containing protein 1 inhibits human nasopharyngeal carcinoma and cervical cancer cell proliferation and induces apoptosis: Involvement of mitochondrial apoptotic pathways.
Ouyang J; Wu M; Huang C; Cao L; Li G
Oncol Rep; 2013 Jan; 29(1):79-86. PubMed ID: 23124592
[TBL] [Abstract][Full Text] [Related]
31. Chidamide, a histone deacetylase inhibitor, functions as a tumor inhibitor by modulating the ratio of Bax/Bcl-2 and P21 in pancreatic cancer.
Zhao B; He T
Oncol Rep; 2015 Jan; 33(1):304-10. PubMed ID: 25384499
[TBL] [Abstract][Full Text] [Related]
32. Anti-tumour activity of a novel coumarin-chalcone hybrid is mediated through intrinsic apoptotic pathway by inducing PUMA and altering Bax/Bcl-2 ratio.
Singh N; Sarkar J; Sashidhara KV; Ali S; Sinha S
Apoptosis; 2014 Jun; 19(6):1017-28. PubMed ID: 24638227
[TBL] [Abstract][Full Text] [Related]
33. The Bcl-2 homology domain 3 mimetic ABT-737 targets the apoptotic machinery in acute lymphoblastic leukemia resulting in synergistic in vitro and in vivo interactions with established drugs.
High LM; Szymanska B; Wilczynska-Kalak U; Barber N; O'Brien R; Khaw SL; Vikstrom IB; Roberts AW; Lock RB
Mol Pharmacol; 2010 Mar; 77(3):483-94. PubMed ID: 20038611
[TBL] [Abstract][Full Text] [Related]
34. Growth inhibition and apoptosis of human B-cell lymphoma in vitro and in vivo by Bcl-2 short hairpin RNA.
Liu Y; Shen Y; Qin C; Shi Y; Rong G; Yu X
Oncol Rep; 2013 Jan; 29(1):244-52. PubMed ID: 23076380
[TBL] [Abstract][Full Text] [Related]
35. Ionizing radiation sensitizes breast cancer cells to Bcl-2 inhibitor, ABT-737, through regulating Mcl-1.
Wu H; Schiff DS; Lin Y; Neboori HJ; Goyal S; Feng Z; Haffty BG
Radiat Res; 2014 Dec; 182(6):618-25. PubMed ID: 25409124
[TBL] [Abstract][Full Text] [Related]
36. Equol induces mitochondria-mediated apoptosis of human cervical cancer cells.
Kim EY; Shin JY; Park YJ; Kim AK
Anticancer Res; 2014 Sep; 34(9):4985-92. PubMed ID: 25202081
[TBL] [Abstract][Full Text] [Related]
37. The Bcl-xL inhibitor, ABT-737, efficiently induces apoptosis and suppresses growth of hepatoma cells in combination with sorafenib.
Hikita H; Takehara T; Shimizu S; Kodama T; Shigekawa M; Iwase K; Hosui A; Miyagi T; Tatsumi T; Ishida H; Li W; Kanto T; Hiramatsu N; Hayashi N
Hepatology; 2010 Oct; 52(4):1310-21. PubMed ID: 20799354
[TBL] [Abstract][Full Text] [Related]
38. T7 Peptide-Conjugated Lipid Nanoparticles for Dual Modulation of Bcl-2 and Akt-1 in Lung and Cervical Carcinomas.
Cheng X; Yu D; Cheng G; Yung BC; Liu Y; Li H; Kang C; Fang X; Tian S; Zhou X; Liu Q; Lee RJ
Mol Pharm; 2018 Oct; 15(10):4722-4732. PubMed ID: 30138565
[TBL] [Abstract][Full Text] [Related]
39. Clitocine induces apoptosis and enhances the lethality of ABT-737 in human colon cancer cells by disrupting the interaction of Mcl-1 and Bak.
Sun JG; Xiang J; Zeng XL; Li X; Wu P; Fung KP; Liu FY
Cancer Lett; 2014 Dec; 355(2):253-63. PubMed ID: 25304383
[TBL] [Abstract][Full Text] [Related]
40. Expression levels of survivin, Bcl-2, and KAI1 proteins in cervical cancer and their correlation with metastasis.
Zhou XL; Wang M
Genet Mol Res; 2015 Dec; 14(4):17059-67. PubMed ID: 26681053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
